Barely Significant
← all excerpts

Clusterin confers gemcitabine resistance in pancreatic cancer.

World J Surg Oncol · 2011 · PMC3120680 · PMID 21609464

Europe PMCDOI
1
hedged sentence
0.0500
closest p · 1.0× alpha
0.0500
boldest claim

The sentences

highly significantP < 0.05actually significant
A highly significant clusterin protein immunoreactivity was shown in pancreatic cancer cells( P < 0.05)(Table 1 ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.